F 0756
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart,
following irregularity reporting guidelines in developed policies and procedures.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
record review and interview, the facility failed to ensure the drug regimen of each resident was reviewed at
least once a month by a pharmacist and ensure pharmacy recommendations were acted upon. This
affected four of five residents reviewed for unnecessary medications (Resident #26, #30, #13, and #33).
The total census was 36.
Findings include:
1. Record review of Resident #26 revealed she was admitted to the facility on [DATE] and had diagnoses
including atrial fibrillation, peripheral vascular disease, heart failure, and cardiomegaly.
Record review of pharmacy communications regarding Resident #26 revealed she had a recommendation
from pharmacy dated 01/03/23 for a digoxin lab with the next blood draw and every six months thereafter.
The recommendation was marked as accepted, however no evidence was found of any digoxin lab draw
being done until 09/05/23. Additionally, a recommendation dated 05/01/23 asked for a comprehensive
metabolic panel on the next lab draw and to be repeated every 12 months thereafter. The recommendation
was marked as accepted, however no evidence was found of a comprehensive metabolic panel for the
resident until 09/15/23.
Interview with the Interim Director of Nursing on 11/01/23 at 2:00 P.M. confirmed the above findings.
3. Review of the medical record for Resident #13 revealed an admission date of 02/10/23. Diagnoses
included aphasia, anxiety disorder, altered mental status, vascular dementia, and other sequela of cerebral
infarction.
Review of the quarterly Minimum Data Set (MDS) 3.0 assessment for Resident #13 dated 08/14/23
revealed Resident #13 had severely impaired cognition.
Medication Regimen reviews with no recommendations were completed for Resident #13 on 04/23, 05/23,
and 07/23.
Pharmacy recommendations were provided for Resident #13 on 03/07/23, 06/06/23, and 08/02/23.
No Medication Regimen reviews or Pharmacy Recommendations were provided for Resident #13 for 09/23
or 10/23.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 7
Event ID:
366267
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366267
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Altercare of Mayfield Village, Inc
290 North Commons Blvd
Mayfield Village, OH 44143
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0756
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Interview on 11/02/23 at 2:30 P.M. with Licensed Practical Nurse/Assistant Director of Nursing (LPN/ADON)
#600, verified there were no Medication Regimen reviews or Pharmacy Recommendations provided for
Resident #13 for 09/23 or 10/23.
4. Review of the medical record for Resident #30 revealed an admission date of 09/30/23. Diagnoses
included localized edema, insomnia, glaucoma, gastro-esophageal reflux disease (GERD), muscle
weakness, and type II diabetes mellitus.
Review of the consultant pharmacist's medication regimen review for Resident #30, dated 10/02/23,
revealed to please add an ICD-10 diagnosis to the diagnosis tab of the electronic medication administration
record (eMAR) to support the use of the following medications: amitriptyline (antidepressant), Eliquis
(anticoagulant), furosemide (diuretic), Januvia (antidiabetic), Lumigan (antiglaucoma), melatonin, insulin
degludec (antidiabetic), and pantoprazole (reduces levels of stomach acid). Further review of the consultant
pharmacist's recommendation form revealed nothing documented under the area titled Follow Through
indicating the recommendation was addressed.
Review of the eMAR for October 2023 revealed a blank space under the diagnosis tab for amitriptyline,
Eliquis, furosemide, Januvia, Lumigan, melatonin, insulin degludec, and pantoprazole.
Interview on 11/02/23 at 8:56 A.M. with Minimum Data Set (MDS) Nurse #608 verified there was diagnosis
added to the diagnosis tab of the eMAR for each medication identified.
Review of the facility policy titled Medication Regimen Review, dated May 2020 revealed findings and
recommendations were to be reported to the Director of Nursing (DON), the attending prescriber, the
Medical Director, and if appropriate, the Administrator. Responses were to be made readily available to he
consultant pharmacist for follow-up. Under item G: The consultant pharmacist medication regimen review
(MRR) and Nursing Documentation Review reports were to be processed as follows and were to be
provided in a written or electronic format: 1) Medication Regimen Review Recommendations to Prescriber
a.) the consultant pharmacist or facility was to provide the report to the responsible prescriber and DON
within seven working days of the review. b.) A copy of the report was to be kept by the facility until the
prescriber's signed response was returned. c.) The prescriber was to accept and act upon
recommendations or reject and provide an explanation for disagreeing. d.) The facility was to maintain
copies of signed reports and make them readily available for the consultant pharmacist for follow-up. 2)
Nursing Documentation Review a.) The report was to be provided by the consultant pharmacist within
seven working days of the review. b.) A copy of the report was to be kept by the facility until the nurse's
response was returned.
2. Review of the medical record for Resident #33 revealed an admission date of 06/15/22 and diagnoses
included diabetes, major depression, hypertension, gout, and dementia with behavioral disturbance. Review
of lab work in the medical record revealed there was no evidence of a Hemoglobin AIC (HGAIC) (a blood
test that reflects an average blood glucose level) or an uric acid level (blood test to check the level of uric
acid which often causes gout).
Review of pharmacy recommendation dated 11/02/22 revealed Consultant Pharmacist #606 recommended
a uric acid level and HGAIC with the next lab draw and repeat both labs in six months. The
recommendation had a check mark by the recommendation that Primary Care Physician (PCP) #608 was
in agreement with the recommendation but with no date.
Review of pharmacy recommendation dated 01/03/23 revealed Consultant Pharmacist #606 recommended
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366267
If continuation sheet
Page 2 of 7
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366267
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Altercare of Mayfield Village, Inc
290 North Commons Blvd
Mayfield Village, OH 44143
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0756
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Resident #33's sliding scale be discontinued and to obtain a HGAIC on the next available lab date and
repeat the HGAIC in three months. The Interim Director of Nursing (DON) placed a X by the
recommendation, check blood sugar twice a day times one week and call if blood sugar below 70 and/or
above 250. There was no date on the form.
Review of pharmacy recommendation dated 03/07/23 revealed Consultant Pharmacist #606 recommended
Resident #33 to have a trial dose reduction of duloxetine (anti-depressant) 20 milligram (mg) by mouth
everyday and monitor for symptoms. Nurse Practitioner (NP) #607 checked that he agreed to the trial and
signed and dated the recommendation for 09/07/23 (six months after the recommendation was made by
the pharmacist).
Review of pharmacy recommendation dated 07/03/23 revealed Consultant Pharmacist #606 recommended
Resident #33's sliding insulin be discontinued and obtain HGAIC next available lab date and repeat HGAIC
in three months. The recommendation had a check mark by the recommendation and was signed by PCP
#608 without a date.
Review of physician order completed by PCP #608 dated 09/08/23 revealed Resident #33's duloxetine was
decreased to 20 mg once a day (per pharmacy recommendation).
Interview on 11/01/23 at 2:52 P.M. with the Interim Director of Nursing verified there was no evidence
Resident #33 had received an HGAIC or uric acid level despite pharmacy recommendations dated
11/02/22, 01/03/23, and 07/03/23. She also verified Resident #33's pharmacy recommendation dated
03/07/23 for the duloxetine dose reduction was not addressed until 09/07/23.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366267
If continuation sheet
Page 3 of 7
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366267
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Altercare of Mayfield Village, Inc
290 North Commons Blvd
Mayfield Village, OH 44143
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
Based on interview, observation, medical record review and policy review the facility did not ensure
Resident #48 was free of a significant medication error. This affected one resident (Resident #48) out of
one resident reviewed for insulin administration. This had the potential to affect eight residents (Resident
#6, #10, #20, #18, #30, #33, #47, and #48) that had orders for insulin.
Residents Affected - Few
Findings include:
Review of medical record for Resident #48 revealed an admission date of 10/13/23 and diagnoses included
diabetes, hypertension, and chronic kidney disease.
Review of care plan dated 10/16/23 revealed Resident #48 had an alteration in blood glucose metabolism
related to her diagnosis of diabetes. Interventions included to administer diabetic medications per physician
orders and observe for signs of hypoglycemia/ hyperglycemia.
Review of November 2023 physician orders for Resident #48 revealed she had an order for lispro (a rapid
acting insulin) insulin pen to administer three units subcutaneously (SQ) with meals scheduled at 7:30 A.M.
and an order for insulin lispro insulin pen to be administered SQ per sliding scale including if blood sugar
was 301 to 350 to administer eight units of insulin before meals and at bedtime (the morning dose was
scheduled for 7:30 A.M.)
Observation on 11/01/23 at 9:02 A.M. revealed Resident #48 was lying in bed when Licensed Practical
Nurse (LPN)/Assistant Director of Nursing (ADON) #600 entered her room to take her blood sugar and
administer her insulin. Resident #48 did not have a breakfast tray in her room. Resident #48 stated to
LPN/ADON #600 that she was upset as she did not understand why LPN/ADON #600 was taking her blood
sugar so late as she had already eaten her breakfast. LPN/ADON #600 took her blood sugar, and it was
306 and LPN/ADON #600 stated that Resident #48 would require sliding scale insulin coverage with her
routine insulin because the blood sugar was elevated. Resident #48 stated to LPN/ADON #600 that her
blood sugar would be high since she ate almost an hour ago and stated that she should not have to get
coverage just because the nurse was late on checking her blood sugar.
Observation on 11/01/23 at 9:17 A.M. revealed LPN/ADON #600 administered Resident #48 her routine
lispro insulin three units and eight units sliding scale lispro insulin to equal 11 units to her left deltoid (arm).
Interview on 11/01/23 at 9:40 A.M. with LPN/ADON #600 verified Resident #48's routine insulin was
scheduled for 7:30 A.M. and her routine lispro insulin was to be administered with meals and her sliding
scale lispro insulin was also scheduled for 7:30 A.M. before breakfast. She verified she obtained her blood
glucose level and administered her insulin at 9:17 A.M. after she had already eaten her breakfast.
Interview on 11/01/23 at 9:55 A.M. with State Tested Nursing Assistant (STNA) #601 revealed breakfast
trays arrived to Resident #48's hall approximately between 7:40 A.M. and 7:50 A.M. everyday. STNA #601
passed Resident #48's breakfast tray between 7:40 A.M. to 8:00 A.M. today, 11/01/23.
Interview on 11/01/23 at 10:10 A.M. with Resident #48 revealed when she was at home, she always used
to take her blood sugar and administer her insulin right before she ate her meal. She revealed she was
upset as frequently the nurses did not check her blood glucose level and/or give her insulin
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366267
If continuation sheet
Page 4 of 7
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366267
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Altercare of Mayfield Village, Inc
290 North Commons Blvd
Mayfield Village, OH 44143
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
until after she ate. She revealed on 11/01/23 she had received her breakfast tray at approximately 8:00
A.M. and ate Cheerios and a breakfast croissant sandwich before LPN/ADON #600, had come in to check
her blood sugar and administer her insulin which was after 9:00 A.M.
Review of the undated facility policy labeled; Insulin Administration revealed it was the facility's policy to
provide guidelines for safe administration of insulin to residents with diabetes. The policy revealed to check
the blood glucose per physician order.
Review of facility policy labeled, Medication Administration- General Guidelines dated May 2020 revealed
medications were administered in accordance with orders of the prescriber. The nurse was to follow the five
rights including right time.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366267
If continuation sheet
Page 5 of 7
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366267
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Altercare of Mayfield Village, Inc
290 North Commons Blvd
Mayfield Village, OH 44143
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0851
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Many
Electronically submit to CMS complete and accurate direct care staffing information, based on payroll and
other verifiable and auditable data.
Based on record review and interview, the facility failed to ensure staffing data was submitted appropriately
to the Centers for Medicare and Medicaid Services (CMS). This had the potential to affect all residents in
the facility. The census was 36.
Findings include:
Review of the CMS staffing data report for quarter three of the 2023 fiscal year (from April 1 to June 30
2023) revealed the facility did not submit staffing data for the affected quarter.
Interview with the Administrator on 10/31/23 at 8:37 A.M. confirmed the above findings.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366267
If continuation sheet
Page 6 of 7
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366267
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Altercare of Mayfield Village, Inc
290 North Commons Blvd
Mayfield Village, OH 44143
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0947
Level of Harm - Potential for
minimal harm
Residents Affected - Many
Ensure nurse aides have the skills they need to care for residents, and give nurse aides education in
dementia care and abuse prevention.
Based on interview, record review and review of facility policy the facility did not ensure State Tested
Nursing Assistant (STNA) #602 received 12 hours of formal in service education within the last year. This
affected one STNA out of three STNAs (#602, #604, and #605) whose personnel files were reviewed for
formal education/training. This had the potential to affect 36 residents.
Findings include:
Review of the personnel file for STNA #602 revealed a hire date of 07/15/03. Review of STNA #602's
education transcript revealed in the last 12 months STNA #604 had 0.75 total hours of training.
Interview on 11/02/23 at 12:20 P.M. with Regional Staff Coordinator #603 verified STNA #602 had only
completed 0.75 hours of training in the last 12 months.
Review of facility policy labeled, Inservice Training dated April 2013 revealed employees must complete all
assigned course work and attend mandatory in-services. The policy revealed each STNA annually must
complete at least 12 hours of formal in-service education.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366267
If continuation sheet
Page 7 of 7